[Form 4] EDGEWELL PERSONAL CARE Co Insider Trading Activity

Edgewell Personal Care Co. director Sit Swan reported an equity grant.

Rhea-AI Filing Summary

Edgewell Personal Care Co. director Sit Swan reported an equity grant. On February 5, 2026, the director was awarded 7,817 restricted stock equivalents at a price of $0 per unit, held directly.

These restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual shareholder meeting, unless the director elects to defer conversion until service on the Board ends.

Insider Trade Summary

Grant/Award: 7,817 shares

Grant/Award 1 txn

Insider Sit Swan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Equivalents 2-5-2026	7,817	$0.00	$0.00

Holdings After Transaction: Restricted Stock Equivalents 2-5-2026 — 7,817 contracts (Direct)

Footnotes (1)

1. F1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Edgewell Personal Care (EPC) report for Sit Swan?

Edgewell Personal Care reported that director Sit Swan received 7,817 restricted stock equivalents on February 5, 2026. The award was priced at $0 per unit and is reported as directly owned derivative securities tied to Edgewell common stock.

How many restricted stock equivalents did Sit Swan receive from Edgewell Personal Care?

Sit Swan received 7,817 restricted stock equivalents linked to Edgewell common stock. After this grant, the Form 4 shows beneficial ownership of 7,817 derivative securities, all held directly, reflecting this equity award to the Edgewell Personal Care board member.

When do Sit Swan’s restricted stock equivalents in Edgewell Personal Care convert to common shares?

The restricted stock equivalents convert into Edgewell common stock on the day preceding the next annual meeting of shareholders. Sit Swan may instead elect to defer this conversion until service on Edgewell’s Board of Directors terminates, as described in the filing footnote.

Is Sit Swan’s reported Edgewell Personal Care transaction a purchase or an award?

The transaction is an award of restricted stock equivalents coded as an acquisition (code A) at a price of $0. This reflects a grant of equity-based compensation to Sit Swan as a director, not an open-market purchase of Edgewell common shares.

Does Sit Swan hold the Edgewell restricted stock equivalents directly or indirectly?

The Form 4 indicates that Sit Swan holds the 7,817 restricted stock equivalents directly, identified with ownership code D. No nature of indirect beneficial ownership is listed, and no footnote reassigns voting or investment power to another entity.

What is the significance of the $0 price for Sit Swan’s Edgewell equity grant?

The $0 price indicates these 7,817 restricted stock equivalents were granted as compensation rather than bought in the market. They represent a right to receive Edgewell common stock under the terms described, including conversion timing around the annual shareholder meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 10:50 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sit Swan

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Equivalents 2-5-2026	$0	02/05/2026		A		7,817		(1)	(1)	Common Stock	7,817	$0	7,817	D

Explanation of Responses:

1. Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

	/s/ LaTanya Langley	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.